CN113462799B - Bacillus anthracis identification method based on chromosome specific probe - Google Patents

Bacillus anthracis identification method based on chromosome specific probe Download PDF

Info

Publication number
CN113462799B
CN113462799B CN202110895338.8A CN202110895338A CN113462799B CN 113462799 B CN113462799 B CN 113462799B CN 202110895338 A CN202110895338 A CN 202110895338A CN 113462799 B CN113462799 B CN 113462799B
Authority
CN
China
Prior art keywords
probe
seq
stranded dna
single stranded
dna shown
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CN202110895338.8A
Other languages
Chinese (zh)
Other versions
CN113462799A (en
Inventor
吕宇飞
刘先凯
王恒樑
王东澍
朱力
潘超
冯尔玲
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Academy of Military Medical Sciences AMMS of PLA
Original Assignee
Academy of Military Medical Sciences AMMS of PLA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Academy of Military Medical Sciences AMMS of PLA filed Critical Academy of Military Medical Sciences AMMS of PLA
Priority to CN202110895338.8A priority Critical patent/CN113462799B/en
Publication of CN113462799A publication Critical patent/CN113462799A/en
Application granted granted Critical
Publication of CN113462799B publication Critical patent/CN113462799B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813Hybridisation assays
    • C12Q1/6816Hybridisation assays characterised by the detection means
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

The invention discloses a bacillus anthracis identification method based on chromosome specific probes. The invention provides a probe set for identifying or assisting in identifying bacillus anthracis, which consists of 51 probes shown in SEQ ID No.1 to SEQ ID No. 51. The probe detects the sequencing result (comprising the second generation or the third generation) of the unknown sample, and as the number of the probes is up to 51, the positive can be judged as long as any probe is detected, the more the detected probes are, the higher the reliability is, and the probes are uniformly distributed on the whole chromosome, so that even if the genome sequence with poor sequencing quality and low coverage is ensured, the electronic probes can be used for inquiring, and whether the sample carries bacillus anthracis can be rapidly, simply, conveniently and efficiently identified.

Description

Bacillus anthracis identification method based on chromosome specific probe
Technical Field
The invention relates to the technical field of biology, in particular to a bacillus anthracis identification method based on chromosome specific probes.
Background
Anthrax is a zoonosis caused by bacillus anthracis. Bacillus anthracis (Bacillus anthracis, bacillus anthracis for short) is an important virulent pathogen and potential biological warfare agent. Humans are infected by contact with a bacteria-bearing animal or animal product and are classified into three types, skin anthrax, lung anthrax and intestinal anthrax, according to different infection pathways. Bacillus anthracis has the characteristics of global popularity, environmental tolerance, infection destructiveness and the like. In the face of anthrax epidemic situations that are frequently occurring and involve a wide range of areas, it is critical to select a rapid, accurate method of identifying bacillus anthracis.
The conventional identification method is a culture identification method, and obviously, the practical requirements cannot be met. Bacillus cereus, bacillus thuringiensis and Bacillus anthracis have very high genomic homology. Researchers consider that bacillus anthracis evolved from bacillus cereus and bacillus thuringiensis in 1-2 thousands of years ago, and obtain two virulence related plasmids of pXO1 and pXO2 in the evolution process, and respectively guide the synthesis of exotoxins and polypeptide capsules, so that the exotoxins and the polypeptide capsules become virulent pathogenic bacteria. The unique sequences on plasmids are used as identification targets and cannot be effectively identified when atypical strains (such as those with plasmid loss) are encountered. There are also primers on the chromosome that are used to distinguish between these two bacteria, but the number of strains is too small and the specificity of the primers is limited.
The rapid development of sequencing technology, more and more strains acquire complete genomic sequences, but NCBI's bacillus anthracis genomic database still contains some non-bacillus anthracis genomic data. The bacillus cereus mixed with the bacillus anthracis genome database is easy to misguide related personnel to carry out subsequent analysis, and a simple, rapid and efficient method for distinguishing bacillus anthracis is needed.
Disclosure of Invention
The invention aims to provide a bacillus anthracis identification method based on chromosome specific probes.
In a first aspect, the invention claims a probe set for the identification or assisted identification of bacillus anthracis.
The probe set for identifying or assisting in identifying bacillus anthracis claimed in the invention can be composed of the following components:
probe 1: single-stranded DNA shown in SEQ ID No. 1;
probe 2: single-stranded DNA shown in SEQ ID No. 2;
probe 3: single stranded DNA shown in SEQ ID No. 3;
probe 4: single-stranded DNA shown in SEQ ID No. 4;
probe 5: single stranded DNA shown in SEQ ID No. 5;
probe 6: single stranded DNA shown in SEQ ID No. 6;
probe 7: single stranded DNA shown in SEQ ID No. 7;
probe 8: single stranded DNA shown in SEQ ID No. 8;
probe 9: single stranded DNA shown in SEQ ID No. 9;
probe 10: single stranded DNA shown in SEQ ID No. 10;
probe 11: single stranded DNA shown in SEQ ID No. 11;
probe 12: single stranded DNA shown in SEQ ID No. 12;
probe 13: single stranded DNA shown in SEQ ID No. 13;
probe 14: single stranded DNA shown in SEQ ID No. 14;
probe 15: single stranded DNA shown in SEQ ID No. 15;
probe 16: single stranded DNA shown in SEQ ID No. 16;
probe 17: single stranded DNA shown in SEQ ID No. 17;
probe 18: single stranded DNA shown in SEQ ID No. 18;
probe 19: single stranded DNA shown in SEQ ID No. 19;
probe 20: single stranded DNA shown in SEQ ID No. 20;
probe 21: single stranded DNA shown in SEQ ID No. 21;
probe 22: single stranded DNA shown in SEQ ID No. 22;
probe 23: single stranded DNA shown in SEQ ID No. 23;
probe 24: single stranded DNA shown in SEQ ID No. 24;
probe 25: single stranded DNA shown in SEQ ID No. 25;
probe 26: single stranded DNA shown in SEQ ID No. 26;
probe 27: single stranded DNA shown in SEQ ID No. 27;
probe 28: single stranded DNA shown in SEQ ID No. 28;
probe 29: single stranded DNA shown in SEQ ID No. 29;
probe 30: single stranded DNA shown in SEQ ID No. 30;
probe 31: single stranded DNA shown in SEQ ID No. 31;
probe 32: single stranded DNA shown in SEQ ID No. 32;
probe 33: single stranded DNA shown in SEQ ID No. 33;
probe 34: single stranded DNA shown in SEQ ID No. 34;
probe 35: single stranded DNA shown in SEQ ID No. 35;
probe 36: single stranded DNA shown in SEQ ID No. 36;
probe 37: single stranded DNA shown in SEQ ID No. 37;
probe 38: single stranded DNA shown in SEQ ID No. 38;
probe 39: single stranded DNA shown in SEQ ID No. 39;
probe 40: single stranded DNA shown in SEQ ID No. 40;
probe 41: single stranded DNA shown in SEQ ID No. 41;
probe 42: single stranded DNA shown in SEQ ID No. 42;
probe 43: single stranded DNA shown in SEQ ID No. 43;
probe 44: single stranded DNA shown in SEQ ID No. 44;
probe 45: single stranded DNA shown in SEQ ID No. 45;
probe 46: single stranded DNA shown in SEQ ID No. 46;
probe 47: single stranded DNA shown in SEQ ID No. 47;
probe 48: single stranded DNA shown in SEQ ID No. 48;
probe 49: single stranded DNA shown in SEQ ID No. 49;
probe 50: single stranded DNA shown in SEQ ID No. 50;
probe 51: single-stranded DNA shown in SEQ ID No. 51.
In a second aspect, the invention claims a probe for identifying or aiding in the identification of bacillus anthracis.
The probe for identifying or assisting in identifying Bacillus anthracis claimed in the present invention may be any one of the probe 1 to the probe 51 in the first aspect described above.
In a third aspect, the invention claims a kit comprising a set of probes as described in the first aspect above or a probe as described in the second aspect above.
In a fourth aspect, the invention claims the use of a set of probes as described in the first aspect hereinbefore or a probe as described in the second aspect hereinbefore or a kit as described in the third aspect hereinbefore, in any of the following:
p1, identifying or assisting in identifying bacillus anthracis;
p2, preparing a product for identifying or assisting in identifying bacillus anthracis;
p3, detecting or assisting in detecting whether the strain to be detected is bacillus anthracis;
p4, preparing a product for detecting or assisting in detecting whether the strain to be detected is bacillus anthracis;
p5, detecting or assisting in detecting whether the target individual carries bacillus anthracis;
p6, preparing a product for detecting or assisting in detecting whether a target individual carries bacillus anthracis.
In a fifth aspect, the invention claims a method for detecting or aiding in the detection of whether the strain to be tested is Bacillus anthracis.
The method for detecting or assisting in detecting whether the strain to be detected is bacillus anthracis or not, which is claimed in the invention, can be a method A
Or method B.
The method a may comprise the steps of:
(A1) Performing whole genome sequencing on the strain to be tested;
(A2) Aligning the sequencing result with the sequence of each probe in the probe set according to the first aspect by bioinformatics software;
(A3) Determining whether the strain to be tested is bacillus anthracis according to the comparison result (A2) as follows: if any probe sequence in the probe group exists in the sequencing result, the strain to be tested is or is candidate to be bacillus anthracis; if any one of the probe sequences in the probe set is not present in the sequencing result, the strain to be tested is not or is not a candidate for Bacillus anthracis.
The method B may include the steps of:
(B1) Hybridization is carried out on each probe in the probe set in the first aspect and the genome of the strain to be detected;
(B2) Determining whether the strain to be tested is Bacillus anthracis according to the result obtained in (B1) as follows: if a positive signal exists after hybridization between any one probe in the probe set and the genome of the strain to be detected, the strain to be detected is or is candidate to be bacillus anthracis; if no positive signal is generated after hybridization between any one probe in the probe set and the genome of the strain to be detected, the strain to be detected is not bacillus anthracis.
In this method, the more probes detected, the more reliable the results, the more probes can avoid misidentification due to poor sequencing quality, or artificially modified bacteria.
The method may be a non-disease diagnostic treatment, such as for the simple detection of whether the strain to be tested is bacillus anthracis, without any disease diagnostic purpose being involved.
In a sixth aspect, the invention claims a method for detecting or aiding in the detection of whether a target individual carries Bacillus anthracis.
The method for detecting or assisting in detecting whether the target individual carries bacillus anthracis can be a method C or a method D.
The method C may include the steps of:
(C1) Extracting the whole genome of bacteria from a sample of a target individual, and then sequencing;
(C2) Aligning the sequencing result with each probe in the probe set according to the first aspect by bioinformatics software;
(C3) Determining whether the target individual carries bacillus anthracis according to the sequence comparison result (C2) as follows: if any one probe sequence in the probe group exists in the sequencing result, the target individual carries or candidates to carry bacillus anthracis; if none of the probe sequences in the probe set is present in the sequencing result, the target individual does not carry or is candidate to not carry B.anthracis.
The method D may include the steps of:
(D1) Extracting the whole genome of the bacteria from the sample of the target individual, and then hybridizing each probe in the probe set according to the first aspect with the extracted genome;
(D2) Determining from the results obtained in (D1) whether the target individual carries bacillus anthracis as follows: if any one probe in the probe set has a positive signal after hybridization with the genome extracted in the step (D1), carrying or candidate carrying bacillus anthracis by the target individual; if no positive signal is generated after hybridization of any one of the probes in the probe set with the genome extracted in the step (D1), the target individual does not carry or is candidate to carry bacillus anthracis.
In this method, the more probes detected, the more reliable the results, the more probes can avoid misidentification due to poor sequencing quality, or artificially modified bacteria.
The method may be a non-disease diagnostic treatment, such as for purely detecting whether the target individual carries bacillus anthracis (e.g. for customs inspection and quarantine), without any disease diagnostic purpose being involved.
In the above aspects, the strain to be tested may be any strain including, but not limited to, a bacillus cereus family strain.
Further, the bacillus cereus family strain may specifically be bacillus anthracis, bacillus cereus or bacillus thuringiensis.
The inventor carries out intensive study on the whole genome sequences of anthrax and non-anthrax bacillus strains in NCBI database, writes a python program by means of local blast, carries out a large number of screening and comparison, and determines a conserved DNA region in the genome sequences of the anthrax bacillus. The invention adopts up to 51 specific probes, and can judge positive if any one probe is detected, and the more the detected probes are, the higher the reliability is, so that even if the genome sequence with poor sequencing quality and low coverage is detected, the electronic probes can be used for inquiring, and whether the sample carries bacillus anthracis can be rapidly, simply, conveniently and efficiently identified.
Drawings
FIG. 1 shows the concept of specific tag interception according to the present invention.
FIG. 2 is a cluster tree of Bacillus anthracis and Bacillus cereus across the genome of Bacillus thuringiensis. Bacillus anthracis adopts BAXXX uniformly, bacillus cereus adopts BCXXXX, and Bacillus thuringiensis adopts BTXXX.
FIG. 3 shows the Blast test results of the BaF_1 probe (SEQ ID No. 1) in NCBI library.
FIG. 4 shows an example of Blast specific results of BaF_1 probe (SEQ ID No. 1) in a single strain, with boxes marked as deleted suspicious B.anthracis. The strains corresponding to the portions marked a and B in the figure are the strains corresponding to a and B, respectively, marked in fig. 3.
Detailed Description
The following detailed description of the invention is provided in connection with the accompanying drawings that are presented to illustrate the invention and not to limit the scope thereof. The examples provided below are intended as guidelines for further modifications by one of ordinary skill in the art and are not to be construed as limiting the invention in any way.
The experimental methods in the following examples, unless otherwise specified, are conventional methods, and are carried out according to techniques or conditions described in the literature in the field or according to the product specifications. Materials, reagents and the like used in the examples described below are commercially available unless otherwise specified.
Example 1 establishment of chromosome-specific Probe-based Bacillus anthracis identification method
The Bacillus anthracis genomic sequence described herein is the Bacillus anthracis standard strain Bacillus anthracis Ames Ancestor chromosomal sequence (GenBank: NC-007530, 25-OCT-2020), and the nucleic acid sequence positions are also calculated using the Bacillus anthracis AmesAncestor chromosome (GenBank: NC-007530, 25-OCT-2020) as standard.
1. The genome of Bacillus anthracis (252 strains in total, table 1) and the genome of a strain other than Bacillus anthracis (4695 strains in total, 83 species of bacteria, table 1) in the genus Bacillus (hereinafter abbreviated as "Bacillus anthracis" and "Bacillus anthracis" respectively for convenience of description) were downloaded from NCBI genome database.
TABLE 1 Bacillus species name and species number information Table (4947 strain)
Figure BDA0003197640600000051
Figure BDA0003197640600000061
Note that: bacillus anthracis it represents suspected bacillus anthracis.
2. A Bacillus anthracis Ames Ancestor chromosomal sequence (GenBank: NC-007530, 25-OCT-2020) fragment (step size 1bp step; length 100 bp) was cut out, and a total of 5227320 fragments 100bp long were cut out, as shown in FIG. 1.
3. 4665794 tags present in Bacillus non-Bacillus anthracis were removed by local blast (blast-2.7.1+), leaving 561526 tags.
4. The Python program was written and the 561526 tags were queried for the tags that appeared in all Bacillus anthracis (Bacillus anthracis total 252 strains, corresponding nomenclature to that in the public database is shown in Table 2), and in this process, it was found that the detection rate of these tags was only 0.07% -2.02% in 12 strains, while the detection rate of these tags was 59.28% -100% in the other 240 strains of Bacillus anthracis. After the analysis of the whole genome cluster tree, none of the 12 strains with very low fragment detection rate was bacillus anthracis (fig. 2). They are eliminated from the genome training set. As a result, we obtained 95823 tags which appeared in all Bacillus anthracis (240 strains).
TABLE 2 Bacillus anthracis Assemble ID and rename correspondence table
Figure BDA0003197640600000062
Figure BDA0003197640600000071
Figure BDA0003197640600000081
Figure BDA0003197640600000091
5. These 95823 tags were combined according to the overlap between the fragments, resulting in 1355 specific fragments, which were between 101bp-915bp in length.
6. Local blast was performed with these 1355 fragments and Bacillus cereus (1118 strain) and Bacillus thuringiensis (622 strain), and the DNA sequences corresponding to each strain were cut out according to the blast result, and made into fasta format.
7. And (3) comparing the files obtained in the step (6) by adopting megaX software, searching SNP loci capable of distinguishing bacillus anthracis from all other near bacteria, and finding that 610 fragments contain the SNP loci.
8. For convenient application and improved detection specificity, we selected 51 sequences containing at least 2 (including 2) SNP sites from the 610 fragments, and cut out the sequences with the lengths of 100-200bp containing the SNP sites as electronic tags (Table 3) for rapid identification of bacillus anthracis.
TABLE 3 specific electronic probe sequences
Figure BDA0003197640600000092
/>
Figure BDA0003197640600000101
/>
Figure BDA0003197640600000111
/>
Figure BDA0003197640600000121
/>
Figure BDA0003197640600000131
Note that: the starting and ending positions in the table were calculated using the chromosomal sequence of Bacillus anthracis standard strain Bacillus anthracis Ames Ancestor (GenBank: NC-007530, 25-OCT-2020) as standard. The probe sequence corresponds to the sequence in the Bacillus anthracis genome.
9. In order to test the specificity of the 51 electronic probes in a larger database, the 51 electronic probes are subjected to online blast inquiry (https:// blast. Ncbi. Nlm. Nih. Gov/blast. Cgi), and the result shows that the 51 electronic probes can only reach 100% of the values of Query Cover and Per. Ident (Percentage of Identity) in Bacillus anthracis, the sequences are completely consistent, the detection in other strains cannot be realized, the values of Query Cover and Per. Ident cannot be 100%, and the sequences are not completely consistent.
Taking Ba_F1 (SEQ ID No. 1) as an example, the test result is shown in FIG. 3, and the result shows that the electronic probe can only reach the values of Query Cover and Per.Ident (Percentage of Identity) of 100% in Bacillus anthracis, specifically shows that the sequences are completely consistent in FIG. 4A, and can not be found in other strains, as shown in FIG. 4B, the values of Query Cover and Per.Ident of 100% can not be satisfied, and the sequences are not completely consistent.
10. In summary, it can be seen that: by using the 51 bacillus anthracis specific electronic probe and the method, whether the strain to be detected is bacillus anthracis and whether a target individual carries bacillus anthracis can be simply and rapidly identified.
The steps are as follows:
(1) Collecting a sample of the strain to be tested or from the target individual, extracting the genome thereof, and extracting the whole genome of the bacteria according to the Bacterial Genomic DNA Extraction kit kit steps.
(2) The genomic samples are sequenced using a sequencer, either second generation sequencing or third generation sequencing.
(3) The sequencing results were aligned and analyzed with the probe sequences using bioinformatics software.
(4) If the sequencing result is 100% identical (i.e., the sequences are completely identical) to any one of the probes, the detection result is positive, the sample carries bacillus anthracis, the more the detected probes are, the more reliable the result is, and the plurality of electronic probes can avoid false identification caused by poor sequencing quality or artificially modified bacteria, and if all the probes are not detected (the sequences are not completely identical), the detection result is negative.
The present invention is described in detail above. It will be apparent to those skilled in the art that the present invention can be practiced in a wide range of equivalent parameters, concentrations, and conditions without departing from the spirit and scope of the invention and without undue experimentation. While the invention has been described with respect to specific embodiments, it will be appreciated that the invention may be further modified. In general, this application is intended to cover any variations, uses, or adaptations of the invention following, in general, the principles of the invention and including such departures from the present disclosure as come within known or customary practice within the art to which the invention pertains. The application of some of the basic features may be done in accordance with the scope of the claims that follow.
<110> military medical institute of the military academy of China's civil liberation army
<120> method for identifying Bacillus anthracis based on chromosome specific probe
<130> GNCLN211968
<160> 51
<170> PatentIn version 3.5
<210> 1
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 1
aacagattgt tgttcgcctg caagggattg gtactgttca aaatccacag ttttgaattt 60
ctagtcagac aggagatcca gagaaagtta tgaaacgaat gggggccatt tttcattgga 120
atgaaccgtt tcaagatata caaaatcatt 150
<210> 2
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 2
acaacccttc atcaattaag gatttaacga atcgttgtcc atgcaagggt tttaaatcct 60
ttaatttatg cgaaccaagc acaggtataa ttcgactatt tatagctctt ttataattgg 120
tgaatgtagt ttctcttact ctttgtttag 150
<210> 3
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 3
aaaaaagatt ttattagact taaaggagaa aaacggagaa tggacggata tccaaactgc 60
atattatgcc cttacatgtg aaggagaaga aagggaatct ctactaaaaa agtccttact 120
gatgtgccaa aagtctggta atatccatta 150
<210> 4
<211> 130
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 4
agaagtggtt tattggtaca aacctacaga agtaagagat gagcattcaa ataatgtgag 60
atataagcaa aagtttaaag cggatacact tcaaaagagt tatcaacaat ttgcagactc 120
ctttggcttt 130
<210> 5
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 5
aacggtatta gtagaagagt tctttacatg aggatgtaca gatacggttg ggaattgcaa 60
gaagcattaa ctactccacc aagaacatat tggcatatgg gtgaggggaa acacaataaa 120
tggctaaaat tagctgaaaa aaatggagtt 150
<210> 6
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 6
tcggtgaatt aaatgattat caggaagcga ctttacgtac ttggaataac aagactgatt 60
ttggaggacg tgtttcaaat gcggccttag gacttacagg tgaagcgggt gaagttgctg 120
atattgttaa aaaagcaatt tatcatgggc 150
<210> 7
<211> 130
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 7
atattaagaa tatgtgtgca gaaggaaaga ttatagctaa gaagattggt aagacgtggg 60
tgattgatag atcaaaatta aaaggagtga ggaaatgagt gaagagaaca aattcggttg 120
ccgtaattgg 130
<210> 8
<211> 100
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 8
tccagctgaa ttacgtgcaa atgctgtgac taaaacaagt gacatcggtt ctgttatccc 60
gcaaacagta ctagataaga ttattgaaaa gattgaagcg 100
<210> 9
<211> 110
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 9
ggaaacaccg tttgaaggac aagcattaga tgttgcgaaa atcaattata aaactttaac 60
agatgcagaa gcagctttac cacttgagta tgaagcaagt gcaatttgga 110
<210> 10
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 10
atgctgaata taatgcagtt tccaaaagtt atgaaaatca acaaaagaac ttagaaaaga 60
aacttagtgc tgaatatgat gcagcatcta aaaattacga ccgacaacaa aaagcacttg 120
agaagtcttt agatgcagaa gttaaagcgt 150
<210> 11
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 11
tgatgaggaa aagtacaatc gtcttaaagc ggtagacgat caaattaatt ctttagatgc 60
gaaaacagca gctgaagata aatattttaa agatcgtgaa aatgcggaaa aacgtgctga 120
tttaaaagtt aaaataagta aagcgaaaaa 150
<210> 12
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 12
gggaaatata ttaaggcatc aggaagaagg gtgggacaac tgtgagttta acattagatg 60
gtaaaccatt aaaacaatta ggtttagcac ttttaccagg atatcaacat ccagcagccc 120
caccagttcg cgactacacc gtttctattc 150
<210> 13
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 13
acctaaagaa gatttagcaa atgaaaaatt cccgttacaa acttacgtta ttccagaaca 60
aattgaataa acttattatc caaaagggct tttacatcaa agctcttttt atttggttaa 120
aaataatgag gtgatacatt gaaacacata aaactttacg ataaacaatt acagttaaaa 180
gcatatctcg aaaacgcatt 200
<210> 14
<211> 100
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 14
tgttactggt aatccacttg atgtaaagct tgtattagaa aataaagtca ctgatattgg 60
gacaatacaa gcagatattg aaaagcgaca gaaagtaaac 100
<210> 15
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 15
gctattttga taaatcacca gaaggaaaag ctcgtacgcc aattacggag aagatggaga 60
ttattgaagg ttaatagatg agacattctc gttttttatg agggtgtctt tttattatgc 120
aatcaattct catgaaagct tgttctcaat 150
<210> 16
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 16
ccccgaaaaa gtaacaggtc aatttgaagt ggtgaaagta gatgcaaatg ataaaacgaa 60
attgttatca ggtgcagaat tcgaagtgta taaagatggc aaaaaggtag cagaactgaa 120
aacaggtgag agtggaaaag tgatgtcacc 150
<210> 17
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 17
gttgacgtat gaaacgtggg aagaaaatga aacgaaaggc gcgctatcag tattaagttg 60
ggcgtataaa gaatataaaa gtgaaattgt atacgcatgt agcttcggag tggaagggat 120
ggtactactg gatcttatta accaagtaaa 150
<210> 18
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 18
atttgagaag cagctgacgc catgtttgta gcttggttgt ttaagttttc tacgttacga 60
tccaagcggt ttaaagttgc accaagtgtt gcacggttac cagcaactgt gttaagggca 120
gtatttaaag ctgaaatagc tgctaatgcg 150
<210> 19
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 19
gaacgcgtaa ggcgctctta tttaaaagtt ttgtagagta ggaggatccg tatgaaacat 60
gaagtatctc ctgtgtcatt aatggaatta gaagattttg caggaaagcg aaacgaagca 120
agtaaagcac atattgatac tgtttcagat 150
<210> 20
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 20
attatggcta cgctgttgtt caaactcttt cgtcatgatg ttgtttgttc ttgcagttgc 60
tttccaatca atccatgaaa agcggtcacc aggtttatag tctctcaaac cgacagaaat 120
ggtagagtct tttgtgaaat ttatatttgc 150
<210> 21
<211> 110
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 21
gtgtaagtac tatcattttt gactgtaaaa attcttttct cttcattaaa tcatttgcaa 60
tcggaattgt tccaagtgac ttccctaaaa acatcggctc gttgtattga 110
<210> 22
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 22
caaccaaaat gcatttctac gacgaagatc agcaaccata aacaaggaat caatcgttgc 60
aaaccaacta aaagcatgaa aaagaccatc tgaaatgagt ccaatatttg ttgtagattt 120
atcatagaaa tggtgccaat gcagcagttg 150
<210> 23
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 23
gtcttgatgt cgtgcgatca tacacatctc cgtggcgttc tatatgagca gttaattgtg 60
acaacgcttg ttttctagaa aggtttttac acatataatg acaatctgat aattgaatga 120
acttccctct cgcccttgtc acagcaacgt 150
<210> 24
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 24
aaacatacac ttggaaaagt tatacgcttc ttattgtaag tatattcgtt acgattaatc 60
tttttctttt cacacctctt ttagacagcg ttgggataga atatgtcgtg cctttcgcct 120
acttcatact agcttccgct gttatagcaa 150
<210> 25
<211> 100
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 25
tgttattcac gctaaaaaac aaatatggga agccatagaa tagacttcgc atcaagcatt 60
tcattactga gatttataca caattttata cttctgtatg 100
<210> 26
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 26
aacgcatacc ccaacctgtg gcacgtccgt ctatctggaa tgtaaatgaa cgccttgacc 60
aatcaccagc agggaattca gtttgtagat tttctgtcca tgatccgttg ataaattgga 120
atacaagaaa agtaacgtaa acatcatttt gaagatcgac actgaatgtc atgtctttac 180
ctttttcaaa attacccatc 200
<210> 27
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 27
ttttgaacac cgactaattg tccagctatt tcttgcgctt taccttccac actttgaact 60
tttagattta attctgtttt tgtggattca atatctttgc tgatttgctc tattgtttct 120
tttttaaccg attccacatc aggaacaacc 150
<210> 28
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 28
tatagaaatc taaaagccca cgtaaattga ctgttaagac taggttagtt gcggctgcgt 60
ttggaagtac gctacgagca tcctcagcag gaattcctaa tgttctaagt agatcataac 120
cactttggag tttgtacatc atttcgttgt 150
<210> 29
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 29
tcatctcgaa atacattcat ttcagcttct aacttatgat tgtcttccgc caacttacat 60
accggacaaa ctacttcacc atttatcttc atgaatcgaa cagtacgttt tcgttctttt 120
ttacaaacct cacaagtatc agaaaggaag 150
<210> 30
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 30
tttaaaataa ggattttgca ttaattccct ctaactgcat ttacggctgc tgcacaaaca 60
gcaattccaa acttttcttc aataatgtaa tcattgtcat ctatgttaac ttgccaatca 120
ccagattcgt ttttaatact cacgtcacga 150
<210> 31
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 31
cctttccatc tttcccccaa tgagtttcta ccttttccca tctaagcact tcatgagcaa 60
ttacatcatt taatttttca acctcattca aatcctcaaa tgagatccaa ctctcttcaa 120
aatgagctac aaagttttca tcaataacgc 150
<210> 32
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 32
aagctaggat gctcatttat tccttttagc cattctgtaa ctaccttatt aatttgttct 60
tgaagctttt ccccttcgtc catcggcaca cctgaaagcc aatattccgc aacctctcca 120
cattcatcgg ttgctcgttc atacaattca 150
<210> 33
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 33
acgtgcagca aagcttggga ttactgcagt cgtttccaat ggaaatgatg gtccaaaacc 60
ttggtctgtt gatgcacctg gaaatgcaag tagcgttata tcagttggag catctacagt 120
ttctattccg tttccaacat tccaagtagc tggttccagc aaaacatacc aaggattatc 180
gttatcaaaa tcagatttcc 200
<210> 34
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 34
tcttaatcga ccctttaaca agcatttggt ctagtataac tgttactctt tcactaagta 60
ttttttatac gttttcacat tggatacacc aacaatccaa atataaaatg aaactatagt 120
atgtggccct tttggtagtt taaattttgc 150
<210> 35
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 35
ttcttttgac tttcttctaa cttcgcaatc atattttcaa ttttatttgt atcggtacta 60
atgtggttac gagcttgatc aatgacgcga ttagataatc caagacgttt cgaaatttca 120
aaggcattac tacgtcctgg tacaccgatt 150
<210> 36
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 36
cggcgttgac cgtgagcctg gactaatgac aacatcacat acatttagaa gcgtcagttc 60
atccacgaac gcgcctaaat aatatgataa tgcttctata tggttgttca tttcattaat 120
tcctccaaag caccaagcat cggtctaaac 150
<210> 37
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 37
tacatggatt gcattagact atcgaaatgt tgctgaaaat cctcccgtta tatttatcga 60
taatgaggtt gagcaaatta ttgaattagc acctaatttt gaaagcttct tacaaaactt 120
aactacgtac aattatgacg aagagtaatt ctctctaaag gagtacgcaa tagtgcaaga 180
tttcattatt agtttacaca 200
<210> 38
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 38
ctgctttaaa accacttgga tttaagaaaa aaagaaacac attttccaaa gctgaaaacg 60
gattttataa gctcattaac atacaaaaaa gccagtttgg agatgctttc tatataaata 120
taggagttca tcctatcggt ctcccgcagc 150
<210> 39
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 39
cgtcccatct aataattctt ctattacttc ttcctcgctt gaaaaactat acaaatgata 60
agtttcttcg tacgtccacg tatttatctc atttgcttct tctatcgtta acttatgtat 120
atccatcctt ctctccccta atcaaatatg ctatatatac tcattcattt ttcgttcctc 180
atttccctct aattgaaata 200
<210> 40
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 40
ttgtaatgga tcagcaattg gatagcatta ctctcaaaaa agcaccacgc tttttcaagg 60
gagtagtctg cccattccca ttacaaagga acgtattgca tctgtagtat gatgtttacg 120
gaggttcctc tttggggaac ctccttttat ttttgtcttt ttctcatgtc ttcatactat 180
aagacatcca aatagctgta 200
<210> 41
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 41
tgatctgtaa atggtatagg tatatctata cccgcttcat atcttgctaa agaggcctcc 60
tccccaagtt caaaaccatt tttatctatt ttatcagcaa cttctgcatt ccccatactt 120
aaactagctt ctacataaaa aaataagaag cctcgtttac aggctccctc atcctctatt 180
caaataatct gcaattgttt 200
<210> 42
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 42
gcctgaaagc atggttaacg caacaattgg caaacagtac gtttcactgg agcaaaatca 60
attatatctc ttaaagaata ctctatctcc aatcatcgtt gctatggaaa gctcgatgga 120
caaagcactt ttgcttgagt ctgaaaaaga caaaggttat ttcttcagat ttgatacttc 180
agagcttatc cgctcgactg 200
<210> 43
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 43
gaatgtcttc tcgaacgcca gcacgtaagc cagcgatttt gacgatgttc tcaatctgta 60
cggtacagat tggtttgcca gctctcgata aaaagtaatt atcatgttcc aatgctttct 120
tttcgaaata cttcgcttta atccgttcgt aacgtatcat gtattttttc aacattaagc 180
tcatgggaac atgtcgccat 200
<210> 44
<211> 110
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 44
ttcttcacga aataagcgaa atgatcttct acaacctctt ctgccaatcc attccgcctt 60
tgtaagcgct tcaattgcaa ggttagacat tccttaatat tccgcgcccc 110
<210> 45
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 45
tgttcaaata ttgaacaacc tctctcatat taacgagttg gattagatat ttcctctgac 60
ttaagcgtat tattcgctcc aagagaatgg tacaatatct ttccatttcc attcacagta 120
acgatatgtt cattattaaa gcttttgaac 150
<210> 46
<211> 100
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 46
tatcttctgt gttactttct ggtgtcgtgc tcgttgactt ctcttctttt tgagatttgt 60
catcagcttt tttaccagag gcattcgttg cctttgcagc 100
<210> 47
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 47
tcgactacat acacttcaaa taagtgaagc acatgagcga ttcctttcgt gataggaatg 60
actgtcatat tgtatagttc atccacataa tatttttctt gcaaaatttt ataaagaggt 120
gcttcctcgc caccagccca atctctagca 150
<210> 48
<211> 150
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 48
ctttaaatgc tacatctttc gtaagccaac ctccgagaaa cgttccaaac cacggtgtat 60
ttatataacc tgccacgact gcaaggacgc caaggacaat catcggatat gtcatgatgc 120
gaggcgattc atgcacatct accttcgtct 150
<210> 49
<211> 100
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 49
ctagcatatt gatgctttcc catttcactc cagcaactcc gcccgcattc cacatactca 60
cctcttgggc aagattgaag tacagtgcaa tgccagatga 100
<210> 50
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 50
acagttaact accttttcta tttataaatt tggaatttcc caatcaattt ctccctcgcc 60
catattagct aaaatcgtat ttactttaga gtatggctta ctcccaaaga aacctcgcct 120
tgctgatagt ggacttggat gtacagattc gataatttga tgatttggat tcgtaattaa 180
cttcttcttc gcctgtgcat 200
<210> 51
<211> 200
<212> DNA
<213> Artificial sequence (Artificial sequence)
<400> 51
caagttcgcg tcattgctca tttaacctta aattttctat cacgaaggaa atatgatttg 60
ttattgcttg aagtacatct atcgtattca catcaaattc accatgattt gaactaacac 120
ataaaacacc aaatatgtga gtttgaatct gtattggtgt ggcaataacc gttctattag 180
aggctgcctt atgactgatt 200

Claims (9)

1. A set of probes for the identification or assisted identification of bacillus anthracis, consisting of:
probe 1: single-stranded DNA shown in SEQ ID No. 1;
probe 2: single-stranded DNA shown in SEQ ID No. 2;
probe 3: single stranded DNA shown in SEQ ID No. 3;
probe 4: single-stranded DNA shown in SEQ ID No. 4;
probe 5: single stranded DNA shown in SEQ ID No. 5;
probe 6: single stranded DNA shown in SEQ ID No. 6;
probe 7: single stranded DNA shown in SEQ ID No. 7;
probe 8: single stranded DNA shown in SEQ ID No. 8;
probe 9: single stranded DNA shown in SEQ ID No. 9;
probe 10: single stranded DNA shown in SEQ ID No. 10;
probe 11: single stranded DNA shown in SEQ ID No. 11;
probe 12: single stranded DNA shown in SEQ ID No. 12;
probe 13: single stranded DNA shown in SEQ ID No. 13;
probe 14: single stranded DNA shown in SEQ ID No. 14;
probe 15: single stranded DNA shown in SEQ ID No. 15;
probe 16: single stranded DNA shown in SEQ ID No. 16;
probe 17: single stranded DNA shown in SEQ ID No. 17;
probe 18: single stranded DNA shown in SEQ ID No. 18;
probe 19: single stranded DNA shown in SEQ ID No. 19;
probe 20: single stranded DNA shown in SEQ ID No. 20;
probe 21: single stranded DNA shown in SEQ ID No. 21;
probe 22: single stranded DNA shown in SEQ ID No. 22;
probe 23: single stranded DNA shown in SEQ ID No. 23;
probe 24: single stranded DNA shown in SEQ ID No. 24;
probe 25: single stranded DNA shown in SEQ ID No. 25;
probe 26: single stranded DNA shown in SEQ ID No. 26;
probe 27: single stranded DNA shown in SEQ ID No. 27;
probe 28: single stranded DNA shown in SEQ ID No. 28;
probe 29: single stranded DNA shown in SEQ ID No. 29;
probe 30: single stranded DNA shown in SEQ ID No. 30;
probe 31: single stranded DNA shown in SEQ ID No. 31;
probe 32: single stranded DNA shown in SEQ ID No. 32;
probe 33: single stranded DNA shown in SEQ ID No. 33;
probe 34: single stranded DNA shown in SEQ ID No. 34;
probe 35: single stranded DNA shown in SEQ ID No. 35;
probe 36: single stranded DNA shown in SEQ ID No. 36;
probe 37: single stranded DNA shown in SEQ ID No. 37;
probe 38: single stranded DNA shown in SEQ ID No. 38;
probe 39: single stranded DNA shown in SEQ ID No. 39;
probe 40: single stranded DNA shown in SEQ ID No. 40;
probe 41: single stranded DNA shown in SEQ ID No. 41;
probe 42: single stranded DNA shown in SEQ ID No. 42;
probe 43: single stranded DNA shown in SEQ ID No. 43;
probe 44: single stranded DNA shown in SEQ ID No. 44;
probe 45: single stranded DNA shown in SEQ ID No. 45;
probe 46: single stranded DNA shown in SEQ ID No. 46;
probe 47: single stranded DNA shown in SEQ ID No. 47;
probe 48: single stranded DNA shown in SEQ ID No. 48;
probe 49: single stranded DNA shown in SEQ ID No. 49;
probe 50: single stranded DNA shown in SEQ ID No. 50;
probe 51: single-stranded DNA shown in SEQ ID No. 51.
2. A kit comprising the probe set of claim 1.
3. Use of the probe set of claim 1 or the kit of claim 2 in any of the following:
p1, identifying or assisting in identifying bacillus anthracis;
p2, preparing a product for identifying or assisting in identifying bacillus anthracis;
p3, detecting or assisting in detecting whether the strain to be detected is bacillus anthracis;
p4, preparing a product for detecting or assisting in detecting whether the strain to be detected is bacillus anthracis;
p5, detecting or assisting in detecting whether the target individual carries bacillus anthracis;
p6, preparing a product for detecting or assisting in detecting whether a target individual carries bacillus anthracis.
4. A use according to claim 3, characterized in that: the strain to be tested is any strain including, but not limited to, a bacillus cereus family strain.
5. The use according to claim 4, characterized in that: the bacillus cereus family strain is bacillus anthracis, bacillus cereus or bacillus thuringiensis.
6. A method for detecting or assisting in detecting whether a strain to be detected is bacillus anthracis, comprising the steps of:
(A1) Performing whole genome sequencing on the strain to be tested;
(A2) Aligning the sequencing result with the sequence of each probe in the probe set of claim 1;
(A3) Determining whether the strain to be tested is bacillus anthracis according to the comparison result (A2) as follows: if any probe sequence in the probe group exists in the sequencing result, the strain to be tested is or is candidate to be bacillus anthracis; if any one of the probe sequences in the probe set is not present in the sequencing result, the strain to be tested is not or is not a candidate for Bacillus anthracis.
7. The method according to claim 6, wherein: the strain to be tested is any strain including, but not limited to, a bacillus cereus family strain.
8. The method according to claim 7, wherein: the bacillus cereus family strain is bacillus anthracis, bacillus cereus or bacillus thuringiensis.
9. A method for detecting or aiding in the detection of a target individual for non-disease diagnostic purposes of bacillus anthracis, comprising the steps of:
(C1) Extracting the whole genome of bacteria from a sample of a target individual, and then sequencing;
(C2) Aligning the sequencing result with each probe in the probe set of claim 1;
(C3) Determining whether the target individual carries bacillus anthracis according to the sequence comparison result (C2) as follows: if any one probe sequence in the probe group exists in the sequencing result, the target individual carries or candidates to carry bacillus anthracis; if none of the probe sequences in the probe set is present in the sequencing result, the target individual does not carry or is candidate to not carry B.anthracis.
CN202110895338.8A 2021-08-05 2021-08-05 Bacillus anthracis identification method based on chromosome specific probe Active CN113462799B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN202110895338.8A CN113462799B (en) 2021-08-05 2021-08-05 Bacillus anthracis identification method based on chromosome specific probe

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN202110895338.8A CN113462799B (en) 2021-08-05 2021-08-05 Bacillus anthracis identification method based on chromosome specific probe

Publications (2)

Publication Number Publication Date
CN113462799A CN113462799A (en) 2021-10-01
CN113462799B true CN113462799B (en) 2023-06-20

Family

ID=77884196

Family Applications (1)

Application Number Title Priority Date Filing Date
CN202110895338.8A Active CN113462799B (en) 2021-08-05 2021-08-05 Bacillus anthracis identification method based on chromosome specific probe

Country Status (1)

Country Link
CN (1) CN113462799B (en)

Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1300333C (en) * 2003-04-17 2007-02-14 中国人民解放军军事医学科学院放射与辐射医学研究所 Preparation of gene chip for digagnosingantrax baiuus and its application
WO2007022337A2 (en) * 2005-08-17 2007-02-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Northern Arizona University Canonical and strain-specific snp genotyping of bacillus anthracis
KR100868248B1 (en) * 2007-03-13 2008-11-12 한양대학교 산학협력단 Novel peptide probes for diagnosing anthrax infection
US8293885B2 (en) * 2002-11-15 2012-10-23 Gen-Probe Incorporated Assay and compositions for detection of Bacillus anthracis nucleic acid
CN102134594B (en) * 2010-12-23 2013-01-02 中国人民解放军南京军区军事医学研究所 Primer and probe sequences and method for detecting Bacillus anthracis, Yersinia pestis and legionella pneumophilia through multiple real-time fluorescence polymerase chain reaction (PCR)
CN105567821A (en) * 2016-01-13 2016-05-11 江苏和创生物科技有限公司 Bacillus-anthracis fluorescence PCR detection kit
CN105002295B (en) * 2015-08-21 2018-06-26 上海市计量测试技术研究院 A set of polynucleotides, method and kit for bacillus anthracis detection
CN109234419A (en) * 2018-11-30 2019-01-18 王素华 Bacillus anthracis double fluorescent quantitative PCR detection kit and detection method
CN112646909A (en) * 2021-01-05 2021-04-13 中国人民解放军军事科学院军事医学研究院 Bacillus anthracis identification method based on specific SNP (single nucleotide polymorphism) sites on chromosome
CN112522429B (en) * 2020-12-16 2021-07-16 中国人民解放军军事科学院军事医学研究院 Method and reagent set for detecting bacillus anthracis by RPA (reverse transcriptase polymerase chain reaction) combined CRISPR (clustered regularly interspaced short palindromic repeats) technology

Patent Citations (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8293885B2 (en) * 2002-11-15 2012-10-23 Gen-Probe Incorporated Assay and compositions for detection of Bacillus anthracis nucleic acid
CN1300333C (en) * 2003-04-17 2007-02-14 中国人民解放军军事医学科学院放射与辐射医学研究所 Preparation of gene chip for digagnosingantrax baiuus and its application
WO2007022337A2 (en) * 2005-08-17 2007-02-22 The Arizona Board Of Regents, A Body Corporate Acting On Behalf Of Northern Arizona University Canonical and strain-specific snp genotyping of bacillus anthracis
KR100868248B1 (en) * 2007-03-13 2008-11-12 한양대학교 산학협력단 Novel peptide probes for diagnosing anthrax infection
CN102134594B (en) * 2010-12-23 2013-01-02 中国人民解放军南京军区军事医学研究所 Primer and probe sequences and method for detecting Bacillus anthracis, Yersinia pestis and legionella pneumophilia through multiple real-time fluorescence polymerase chain reaction (PCR)
CN105002295B (en) * 2015-08-21 2018-06-26 上海市计量测试技术研究院 A set of polynucleotides, method and kit for bacillus anthracis detection
CN105567821A (en) * 2016-01-13 2016-05-11 江苏和创生物科技有限公司 Bacillus-anthracis fluorescence PCR detection kit
CN109234419A (en) * 2018-11-30 2019-01-18 王素华 Bacillus anthracis double fluorescent quantitative PCR detection kit and detection method
CN112522429B (en) * 2020-12-16 2021-07-16 中国人民解放军军事科学院军事医学研究院 Method and reagent set for detecting bacillus anthracis by RPA (reverse transcriptase polymerase chain reaction) combined CRISPR (clustered regularly interspaced short palindromic repeats) technology
CN112646909A (en) * 2021-01-05 2021-04-13 中国人民解放军军事科学院军事医学研究院 Bacillus anthracis identification method based on specific SNP (single nucleotide polymorphism) sites on chromosome

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
Use of High-Resolution Melting and Melting Temperature-shift assays for specific detection and identification of Bacillus anthracis based on single nucleotide discrimination;Sylviane Derzelle等;Journal of Microbiological Methods;第87卷(第2期);第195-201页 *
一种快速定量检测炭疽杆菌方法的建立;陈苏红等;中华检验医学杂志;第26卷(第2期);第98-100页 *

Also Published As

Publication number Publication date
CN113462799A (en) 2021-10-01

Similar Documents

Publication Publication Date Title
JP4714883B2 (en) Subtractive hybridization based on microarray
CN111793704B (en) SNP molecular marker for identifying Brucella vaccine strain S2 and wild strain and application thereof
CN113481311B (en) SNP molecular marker for identifying Brucella vaccine strain M5 and application thereof
CN110527730A (en) It is a kind of based on the Shiqu echinococcus detection kit of RPA technology and its application
CN109988847B (en) Method for detecting CNV (CNV) marker of ShE gene of Tekaka sheep and application of CNV marker
WO2019212138A1 (en) Internal control substance for discovering cross-contamination between samples for next generation sequencing
CN113462799B (en) Bacillus anthracis identification method based on chromosome specific probe
Yu et al. Rapid and efficient detection of 16SrI group areca palm yellow leaf phytoplasma in China by loop-mediated isothermal amplification
CN116410955B (en) Two novel endonucleases and application thereof in nucleic acid detection
CN103014135A (en) Method for identifying mycobacterium tuberculosis
US20230287520A1 (en) Methods of detecting and typing pathogenic strains of francisella tularensis
CN111197098A (en) Method for detecting mycobacterium tuberculosis from sputum
CN115786541B (en) SNP molecular marker, primer probe, kit, method and application for identifying Brucella vaccine strain A19
Kamusoko et al. Purification and amplification of DNA from cellulolytic bacteria: Application for biogas production from crop residues
Swain et al. Molecular identification and phylogeny of Myzomyia and Neocellia series of Anopheles subgenus Cellia (Diptera: Culicidae)
KR101985864B1 (en) Composition for detecting Breast Cancer and Ovarian Cancer and uses thereof
CN112980974B (en) Yersinia pestis identification method based on chromosome specific probe
CN114360646A (en) Method and device for tracing source and evaluating pathogenicity of SARS coronavirus
CN110964850B (en) Identification of morinda officinalis mosaic virus, ribosomal RNA gene of morinda officinalis mosaic virus and application of ribosomal RNA gene
Verma et al. Molecular investigation of bovine tropical theileriosis outbreak in an organized dairy cattle farm in Madhya Pradesh, India
CN115725761B (en) Core gene design-based Solanaceae Ralstonia detection primer and application thereof
JP3103882B2 (en) A base sequence specific to Babesia obata and a method for detecting Babesia obata using it
Alhindi et al. P32 Gene PCR Evaluation for Capripox’s Diagnostic Potential and Immunogenic Effect
Tomé Classification of dermatophytes by a multilocus phylogenetic approach based on tef-1α, beta tubulin and its genes
CN117904338A (en) Identification method of Brucella suis and Brucella canis based on specific sequences and SNP loci

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
GR01 Patent grant
GR01 Patent grant